Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Palmitate for PONV Prophylaxis in Open Surgery
NCT06997419Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jul 2025
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of dexamethasone in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Incidence of Postoperative Nausea and Vomiting at 24 hours. Started Jul 2025; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06997419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06997419.